It is proposed to study the role of protein phosphorylation in neurotransmitter release from presynaptic terminals in mammalian brain and the effects of psychoactive drugs on this system. This proposal will focus on two neuronal phosphoproteins: synapsin I, a synaptic vesicle-associated protein that is phosphorylated at specific sites by cAMP- and Ca/calmodulin-dependent protein kinases, and """"""""87k"""""""" protein, a cytosolic protein that is specificallly phosphorylated in nerve terminals by protein kinase C. The pharmacological regulation of the phosphorylation of synapsin I and 87k will be studied with standard endogenous ATP labelng and """"""""back-phosphorylation"""""""" techniques in brain slice and brain synaptosome preparations using agents that affect presynatpic receptors. We will sequence the regions on synapsin I and 87k containing the phosphoacceptor sites. We will then synthesize peptides of these sites and raise antibodies specific for either the phospho or de-phospho forms of these peptides. We will study the effect of these phosphosite peptides and antibodies (a) on the interaction of synapsin I with synaptic vesicles and (b) on neurotransmitter release from synaptosomes in """"""""microinjection"""""""" experiments. We will isolate and characterize the synaptic vesicle component to which synapsin I binds. A """"""""microinjection"""""""" technique that we have just developed will be used to introduce into brain synaptosomes molecules that modulate the phosphorylation of either synapsin I or 87k, and appropriate phosphosite peptides and antibodies. Neurotransmitter release will be studied in these same preparations under those conditions found to regulate the phosphorylation of these two phosphosubstrates. We will study the effects of several classes of psychoactive drugs on the phosphorylation of synapsin I and 87k and on neurotransmitter release. Also, brains and CSF from schizophrenic individuals and individuals with affective disorders will be examined for any changes in synapsin I or other phosphoproteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH039327-08
Application #
3377256
Study Section
Special Emphasis Panel (BPNA)
Project Start
1983-09-01
Project End
1991-08-31
Budget Start
1990-09-01
Budget End
1991-08-31
Support Year
8
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Tomiyama, Katsunori; Makihara, Yasuyuki; Yamamoto, Hiroshi et al. (2006) Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction 'knockout'. Eur Neuropsychopharmacol 16:437-45
Venton, B Jill; Seipel, Andrew T; Phillips, Paul E M et al. (2006) Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 26:3206-9
Hilfiker, Sabine; Benfenati, Fabio; Doussau, Frederic et al. (2005) Structural domains involved in the regulation of transmitter release by synapsins. J Neurosci 25:2658-69
Gitler, Daniel; Takagishi, Yoshiko; Feng, Jian et al. (2004) Different presynaptic roles of synapsins at excitatory and inhibitory synapses. J Neurosci 24:11368-80
Nally, Rachel E; Kinsella, Anthony; Tighe, Orna et al. (2004) Ethologically based resolution of D2-like dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3',5'-monophosphate-regulated phosphoprotein of 32 kDa ""knockout"" mutants congenic on the C57BL/6 genetic back J Pharmacol Exp Ther 310:1281-7
Giovedi, Silvia; Darchen, Francois; Valtorta, Flavia et al. (2004) Synapsin is a novel Rab3 effector protein on small synaptic vesicles. II. Functional effects of the Rab3A-synapsin I interaction. J Biol Chem 279:43769-79
Gitler, Daniel; Xu, Yimei; Kao, Hung-Teh et al. (2004) Molecular determinants of synapsin targeting to presynaptic terminals. J Neurosci 24:3711-20
Giovedi, Silvia; Vaccaro, Paola; Valtorta, Flavia et al. (2004) Synapsin is a novel Rab3 effector protein on small synaptic vesicles. I. Identification and characterization of the synapsin I-Rab3 interactions in vitro and in intact nerve terminals. J Biol Chem 279:43760-8
Bloom, Ona; Evergren, Emma; Tomilin, Nikolay et al. (2003) Colocalization of synapsin and actin during synaptic vesicle recycling. J Cell Biol 161:737-47
Nally, Rachel E; McNamara, Fergal N; Clifford, Jeremiah J et al. (2003) Topographical Assessment of Ethological and Dopamine Receptor Agonist-Induced Behavioral Phenotype in Mutants with Congenic DARPP-32 'Knockout'. Neuropsychopharmacology 28:2055-63

Showing the most recent 10 out of 130 publications